ERAS erasca.com: Rasio total nilai perusahaan marang pendapatan

Simbol resmi perusahaan erasca.com (ERAS)

Competition with pharma behemoths and the risk of new therapies are pressuring the capitalization of Erasca, Inc. (ERAS), as evidenced by the enterprise value-to-revenue ratio, where the parameter value equals 0.00. Optimization is possible through breakthroughs in melanoma treatment and M&A transactions, despite the lack of operating margin and high fixed costs during the clinical trial stage.

Multiplikator EV/Sales Erasca Corp (ERAS): kanggo periode 23.11.2025 - 20.11.2026

Erasca Oncology - rincian analitis lan metrik utama (ERAS)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:Erasca, Inc., ERAS
Sampel barang Erasca Corp

For the biopharmaceutical startup Erasca, Inc. (ERAS), which develops RAS-mutation inhibitors, the Enterprise Value-to-Sales multiple reflects market expectations for future breakthroughs. This metric compares the total value of the business (Enterprise Value) to annual revenue, excluding the impact of debt load. The value is calculated as the ratio of the sum of market capitalization and net debt to revenue. The indicator's trend allows for an assessment of the premium paid for scientific potential. It is critical for investors to correlate this momentum with the pace of R&D development.

Analisis pesaing Erasca, Inc.

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan DCTH|YMAB: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Aura Corp|CADL: Multiplikator EV/Sales|ARAY - Rasio total nilai perusahaan marang pendapatan|SLS (SELLAS Life Sciences Group, Inc.) - Multiplikator EV/Sales|ACTU: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan citiusonc.com (CTOR)|Rasio total nilai perusahaan marang pendapatan TuHURA Biosciences|Rasio nilai perusahaan marang pendapatan Protara Therapeutics TARA|Fate Therapeutics (FATE) - Multiplikator nilai perusahaan marang pendapatan|WHWK - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan TScan Therapeutics Inc|championsoncology.com (CSBR) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan XBIT|Nilai perusahaan marang pendapatan CVM|Rasio nilai perusahaan marang pendapatan OSTX (OS Therapies Incorporated)|Multiplikator EV/Sales RADX|ARTV: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales ANL (Adlai Nortye Ltd)|VERU - Nilai perusahaan marang pendapatan|tempesttx.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan XLO (xiliotx.com)|RENB: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Mural Oncology plc|Rasio nilai perusahaan marang pendapatan Kairos Pharma Inc|OKUR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales GDTC|CRIS (Curis) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan apollomicsinc.com APLM|THAR: Rasio nilai perusahaan marang pendapatan|advanbiomed.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Rasio nilai perusahaan marang pendapatan|Sunshine Biopharma Inc. (SBFM) - Multiplikator EV/Sales|XBIO (Xenetic Bio) - Multiplikator EV/Sales|Salarius Pharmaceuticals Inc (SLRX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PPBT|Multiplikator EV/Sales American Oncology Network Inc (AONC)|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan